Published: 2016-09-15

DOI: https://doi.org/10.12816/0031101
DOI: https://doi.org/10.12816/0031102
DOI: https://doi.org/10.12816/0031103
DOI: https://doi.org/10.12816/0031104
DOI: https://doi.org/10.12816/0031105
DOI: https://doi.org/10.12816/0031106
DOI: https://doi.org/10.12816/0031107
DOI: https://doi.org/10.12816/0031108
DOI: https://doi.org/10.12816/0031109

Salivary Immunoglobulin A Assessment in Lymphoma Patients before and after Chemotherapy

Mohammed H. Abdulshaheed, Fawaz D. Al-Aswad, Haider N. Salh

65-68

DOI: https://doi.org/10.12816/0031110
DOI: https://doi.org/10.12816/0031111
DOI: https://doi.org/10.12816/0031112
DOI: https://doi.org/10.12816/0031129
DOI: https://doi.org/10.12816/0031113
DOI: https://doi.org/10.12816/0031114
DOI: https://doi.org/10.12816/0031115
DOI: https://doi.org/10.12816/0031116
DOI: https://doi.org/10.12816/0031117
DOI: https://doi.org/10.12816/0031130
DOI: https://doi.org/10.12816/0031118
DOI: https://doi.org/10.12816/0031119
DOI: https://doi.org/10.12816/0031120
DOI: https://doi.org/10.12816/0031121
DOI: https://doi.org/10.12816/0031122
DOI: https://doi.org/10.12816/0031123
DOI: https://doi.org/10.12816/0031124
DOI: https://doi.org/10.12816/0031125
DOI: https://doi.org/10.12816/0031126
DOI: https://doi.org/10.12816/0031127
DOI: https://doi.org/10.12816/0031128